➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Colorcon
Mallinckrodt
Dow
McKesson

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Exela Pharma Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for EXELA PHARMA, and what generic alternatives to EXELA PHARMA drugs are available?

EXELA PHARMA has eighteen approved drugs.

There are nine US patents protecting EXELA PHARMA drugs.

Summary for Exela Pharma
US Patents:9
Tradenames:18
Ingredients:17
NDAs:18
Patent Litigation for Exela Pharma: See patent lawsuits for Exela Pharma

Drugs and US Patents for Exela Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Pharma NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-003 Jul 13, 2018 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Exela Pharma ZINC CHLORIDE zinc chloride INJECTABLE;INJECTION 212007-001 May 21, 2021 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Exela Pharma VERAPAMIL HYDROCHLORIDE verapamil hydrochloride SOLUTION;INTRAVENOUS 018925-001 Mar 30, 1984 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Exela Pharma CAFFEINE CITRATE caffeine citrate SOLUTION;ORAL 077304-001 Sep 21, 2006 AA RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Exela Pharma ELCYS cysteine hydrochloride SOLUTION;INTRAVENOUS 210660-001 Apr 16, 2019 RX Yes Yes 10,912,795 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Exela Pharma ELCYS cysteine hydrochloride SOLUTION;INTRAVENOUS 210660-001 Apr 16, 2019 RX Yes Yes 10,653,719 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Exela Pharma NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-001 Mar 8, 2017 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
McKinsey
Express Scripts
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.